Deep Flaws in FDA's Device Oversight, and Patient Harm, Exposed in Lawsuits, Records "What is the threshold for the FDA to step in and do something?" Dec 24, 2023
Cannabis Exposure During Pregnancy; Tirzepatide Cessation and Weight Gain Also in TTHealthWatch: newer vaccine technologies in adults Dec 16, 2023 podcast
Stopping Tirzepatide Led to Weight Gain, Trial Shows But sustained treatment kept the pounds off Dec 13, 2023
Metformin for Diabetes in Pregnancy: Maybe Not, Trial Says New trial complicates findings of previous studies Dec 12, 2023
GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients Association strongest in patients with overweight, obesity Dec 07, 2023
Quick Albuminuria Reduction Key Factor in Finerenone's Efficacy 4-month UACR reduction mediated 84% of kidney treatment effect Dec 05, 2023
Pharmacists Can Spur Switch to Recommended Drugs for Diabetes Patients With CVD Intervention persuaded VA physicians to adjust care, helped lower HbA1c Dec 04, 2023
Orphan Drug Costs; Digital Devices for Diabetes Also in TTHealthWatch: smoking cessation benefits Dec 02, 2023 podcast
'Alexa, Titrate My Insulin': AI App Boosts Glycemic Control in Randomized Trial Voice-based app helped users to titrate basal insulin at home Dec 01, 2023
Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Events Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
Brolucizumab Noninferior to Aflibercept for Diabetic Macular Edema At a non-approved dose, the anti-VEGF drug had similar outcomes as rival Nov 17, 2023
Even Small Diabetes Distress Changes Clinically Important Researchers calculated cutoffs for significant DDS-17 scale changes Nov 15, 2023
One Copeptin Test More Accurate as Diagnostic for AVP Deficiency However, this test was more complicated, with more side effects, researchers note Nov 15, 2023
Diabetes Linked to Higher Colorectal Cancer Risk Associated risks highest in those with recent diagnoses Nov 14, 2023
Hospitalizations After Fake Ozempic; Abortion Rights Win Big; Ketamine Use Booms Health news and commentary from around the Web gathered by ֱ staff Nov 08, 2023
Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplant Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trial Trial tested BI 690517 with and without empagliflozin Nov 06, 2023
ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease But ZENITH-CKD trial had to pivot to only using low-dose zibotentan due to fluid retention Nov 05, 2023
Heat and Cardiovascular Death; Time-Restricted Eating or Caloric Restriction in T2D Also in TTHealthWatch: managing nasal airway obstruction Nov 04, 2023 podcast
Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deaths Health news and commentary from around the Web gathered by ֱ staff Oct 30, 2023
Another Study Highlights Metformin's Dementia Protection Properties Association appeared irrespective of HbA1c level Oct 25, 2023
CVS Pulls Phenylephrine Cold Meds; Doc's Murder/Suicide; Red Meat and Diabetes Health news and commentary from around the Web gathered by ֱ staff Oct 20, 2023
Highly Potent Statin Stands Out for Diabetes, Cataract Risks Head-to-head comparison of rosuvastatin vs atorvastatin in LODESTAR trial Oct 19, 2023
Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
Inflammation of the Aorta; Afib in the Hospital Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
CPAP Turns in Mixed Results for Patients With Diabetic Eye Disease Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancy However, no FDA-approved systems have a pregnancy indication yet Oct 05, 2023
Mixed Bag for Early Metformin in Gestational Diabetes EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023
FDA Approves Another SGLT2 Inhibitor for Treating CKD Empagliflozin adds indication in adults, regardless of diabetes status Sep 22, 2023
FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes We haven't seen "the best version of this device," said panel member Sep 22, 2023
Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Say Privacy policies, terms of sale often are unclear Sep 18, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast